Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Eravacycline Impurity 22(Hydrochloride)
Eravacycline Impurity 22(Hydrochloride)
  • Eravacycline Impurity 22(Hydrochloride)
  • Eravacycline Impurity 22(Hydrochloride)
  • Eravacycline Impurity 22(Hydrochloride)
  • Eravacycline Impurity 22(Hydrochloride)
  • Eravacycline Impurity 22(Hydrochloride)

Eravacycline Impurity 22(Hydrochloride) NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Eravacycline Impurity 22(Hydrochloride) CAS No.: 6628-74-6
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31
Molecular formula: C6H11NO2.HCl

Eravacycline Impurity 22(Hydrochloride),6628-74-6

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

Product Information

  • Product Code:E062022A

  • English Name:Eravacycline Impurity 22(Hydrochloride)

  • English Alias:2-(pyrrolidin-1-yl)acetic acid hydrochloride

  • CAS No.:6628-74-6

  • Molecular Formula:C₆H₁₁NO₂·HCl

  • Molecular Weight:165.62

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, suitable for Eravacycline impurity analysis and quality control.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.3% in methanol-water mixture within 6 months.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 22 in Eravacycline API and formulations, controlling content to meet ICH Q3A standards (single impurity limit ≤0.1%).

  • Process Optimization Research:Monitors impurity formation during Eravacycline synthesis, reducing generation by >30% by adjusting pyrrolidine substitution temperature (e.g., 40-50℃) and reaction time.

  • Method Validation:Serves as a standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.01 ng/mL).

Background Description

Eravacycline, a novel tetracycline antibiotic, is used for treating complicated intra-abdominal infections by inhibiting bacterial protein synthesis. Impurity 22, a process-related impurity in its synthesis, may originate from hydrochlorination side reactions of pyrrolidine acetic acid intermediates or residual during purification. Its pyrrolidine ring, carboxyl group, and hydrochloride may affect drug water solubility, stability, and antibacterial activity. Strict impurity control for antibiotics is critical to drug quality, making research on this impurity essential.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 5 minutes, with LOD of 0.005 ng/mL for trace impurity analysis.

  • Formation Mechanism:Formed by reaction of pyrrolidin-1-ylacetic acid with hydrogen chloride gas in ethanol; optimizing reaction temperature and HCl dosage inhibits side reactions.

  • Safety Evaluation:In vitro cytotoxicity shows IC₅₀ of 210.5 μM against Vero cells (Eravacycline IC₅₀=8.7 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor degradation under high temperature and humidity conditions.

NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 




Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-03-21
$0.00/10mg
VIP8Y
Guangzhou PI PI BIOTECH INC
2022-04-21
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-02-26
$0.00/25KG
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2025-05-15
INQUIRY